COMMUNIQUÉ DE PRESSE publié le 17/04/2024 à 07:15, il y a 5 mois 2 jours Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera Spexis AG extends moratorium and receives payment for antibiotics program sale while reverting lonodelestat license from Santhera Spexis AG Moratorium Extension Antibiotics Program Sale Lonodelestat License Santhera
COMMUNIQUÉ DE PRESSE publié le 08/02/2024 à 07:15, il y a 7 mois 11 jours Spexis announces closing of sale of preclinical antibiotics program to Basilea Spexis AG announces the closing of the sale of a preclinical antibiotics program to Basilea, which will pay up to CHF 2 million for the program. The program targets Gram-negative bacteria, including multidrug-resistant strains. The sale is part of Spexis' strategy to divest non-core programs and assets to focus on rare diseases and oncology Spexis AG Basilea Preclinical Antibiotics Program Gram-negative Bacteria Multidrug-resistant Strains
COMMUNIQUÉ DE PRESSE publié le 08/11/2023 à 07:15, il y a 10 mois 11 jours Spexis to file an application for a debt-restructuring moratorium
COMMUNIQUÉ DE PRESSE publié le 01/11/2023 à 07:20, il y a 10 mois 18 jours Spexis Announces Changes to the Executive Committee
COMMUNIQUÉ DE PRESSE publié le 06/10/2023 à 07:30, il y a 11 mois 13 jours Spexis to host business update conference call on October 9, 2023
COMMUNIQUÉ DE PRESSE publié le 29/09/2023 à 07:25, il y a 11 mois 20 jours Spexis provides business update and announces financial results for the first half of 2023
COMMUNIQUÉ DE PRESSE publié le 28/09/2023 à 07:30, il y a 11 mois 21 jours Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology
COMMUNIQUÉ DE PRESSE publié le 15/08/2023 à 07:25, il y a 1 année 1 mois Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies
COMMUNIQUÉ DE PRESSE publié le 18/07/2023 à 12:26, il y a 1 année 2 mois Original-Research: Spexis AG (von First Berlin Equity Research GmbH): Buy
COMMUNIQUÉ DE PRESSE publié le 30/06/2023 à 07:15, il y a 1 année 2 mois Spexis announces engagement with Maxim Group LLC as M&A advisor to support evaluation of strategic transactions
Publié le 19/09/2024 à 17:45, il y a 52 minutes Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Publié le 19/09/2024 à 17:45, il y a 52 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:45, il y a 52 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:30, il y a 1 heure 7 minutes Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Publié le 19/09/2024 à 17:00, il y a 1 heure 37 minutes Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Publié le 19/09/2024 à 15:45, il y a 2 heures 52 minutes eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Publié le 19/09/2024 à 15:20, il y a 3 heures 17 minutes Taurus secures "Best Digital Assets Solution" at 2024 Global BankTech Awards
Publié le 19/09/2024 à 15:01, il y a 3 heures 36 minutes ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members
Publié le 19/09/2024 à 17:52, il y a 44 minutes PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Publié le 19/09/2024 à 17:52, il y a 44 minutes PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Publié le 19/09/2024 à 17:52, il y a 45 minutes EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board
Publié le 19/09/2024 à 17:45, il y a 52 minutes AFG Holding SA acquiert une participation majoritaire dans le groupe allemand Access Holding et prend ainsi le contrôle de